Evidence-based traditional Siddha formulations for prophylaxis and management of respiratory symptoms in COVID-19 pandemic-a review.
Biocatal Agric Biotechnol
; 35: 102056, 2021 Aug.
Article
in English
| MEDLINE | ID: covidwho-1260667
ABSTRACT
The recent outbreak of COVID-19 is attributed to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This viral disease is rapidly spreading across the globe, including India. The mainstay in managing the disease is supportive care, nutrition, and preventing further progression in the absence of proven antiviral drugs. Currently two vaccines Covishield and Covaxin are administered in India. Long-term plans of developing most reliable mRNA-based vaccines are also underway for the future method of prophylaxis. The Siddha system of medicine's holistic approach emphasizes lifestyle modification, prophylactic interventions, and dietary management to boost the host immunity and treatment with herbal medicines and higher-order medicines as the case may be. In this review, a brief outline of the disease COVID-19, Coronavirus, evidence-based traditional Siddha interventions for respiratory ailments and immune boosters highlighting the relevant published research on individual herbs are dealt, which pave way for further research on drug repurposing for COVID-19. Historical evidence on the prevention and treatment of infections especially antivirals in Siddha classics is studied.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Topics:
Long Covid
/
Traditional medicine
/
Vaccines
Language:
English
Journal:
Biocatal Agric Biotechnol
Year:
2021
Document Type:
Article
Affiliation country:
J.bcab.2021.102056
Similar
MEDLINE
...
LILACS
LIS